By Sandra Dalton, Staff Writer When researchers analyzed the serious adverse event reports made to the U.S. Food and Drug Administration (FDA) in 2014, they found that reports filed by drug makers were incomplete more than half of the time, while more than 86% of those filed directly by health professional and consumers were complete. The FDA’s … [Read more...]
Document Claims Drug Makers Deceived a Top Medical Journal
On March 1, 2016, The New York Times put out an article questioning whether or not two major pharmaceutical companies deceived a top medical journal in order to protect their drug. The two companies, Johnson & Johnson and Bayer, are said to have misled editors at The New England Journal of Medicine in regards to their anticlotting drug, … [Read more...]
Chris Bosh Back on Blood Thinners
According to the Associated Press, basketball star Chris Bosh has started taking blood thinners to treat a blood clot in his leg, for the second time. Even if you don’t follow basketball, you probably recognize him from TV ads for Xarelto (rivaroxaban). As discussed in the ads, Xarelto is typically prescribed to lower the risk of stroke caused … [Read more...]
Xarelto Bleeding
Have you seen the ad where Kevin Nealon says he prefers Xarelto (rivaroxaban) over warfarin because it allows him to eat a healthy salad if he wants to? His statement makes it sound like Xarelto is a healthier choice, but the reason why you can eat leafy greens while taking Xarelto is the very thing that makes it such a dangerous medication. … [Read more...]
Defective Device Used in Xarelto Trial
The European Medicines Agency (EMA) is questioning the results of a clinical trial called ROCKET AF, that compared Xarelto (rivaroxaban) with warfarin for preventing stroke in patients with nonvalvular atrial fibrillation (AFib). A defective device was used in the trial, and regulators are worried that the defect may have resulted in inaccurate … [Read more...]
Recent Comments